Cornelius, North Carolina Clinical Trials

A listing of Cornelius, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 90 clinical trials
XTX101 in Patients With Advanced Solid Tumors

This is a first-in-human, Phase 1/2, multicenter, open-label study designed to evaluate the safety and tolerability of XTX101 as monotherapy in patients with advanced solid tumors.

Carolina BioOncology Institute
 (5.0 away) Contact site
  • 08 Sep, 2021
  • +1 other locations
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian Fallopian Tube or Primary Peritoneal Cancer

This phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). Chemotherapy drugs, such as pegylated liposomal doxorubicin hydrochloride, work in different ways to stop the growth of tumor …

undifferentiated carcinoma
Novant Health Presbyterian Medical Center Huntersville
 (5.0 away) Contact site
  • 15 Sep, 2021
  • +757 other locations
Patient Retrospective Outcomes (PRO)

This study will evaluate de-identified (anonymous) data in subject medical charts to review the clinical outcomes of various treatment approaches in the treatment of chronic pain.

spinal cord
chronic pain
Carolinas Research Institute, PLLC
 (4.6 away) Contact site
  • 12 Sep, 2021
  • +103 other locations
RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine …

Carolinas Research Institute, PLLC
 (4.6 away) Contact site
  • 15 Sep, 2021
  • +101 other locations
Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products

Primary Objective: This is a study to investigate the feasibility of harvesting, expanding in culture, and freezing circulating tumor cells and immune cells from cancer patients and healthy volunteers.

neutrophil count
tumor cells
liver metastasis
Carolina BioOncology Institute
 (5.0 away) Contact site
  • 25 Jan, 2021
  • 1 location
STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaffold Use

This is a retrospective chart review performed at multiple clinics aimed at providing real-world evidence of the use and safety of the P4HB scaffold. Data on patient demographics, relevant medical history, product and procedure used, product safety, and outcome measures will be collected as available.

HKB Cosmetic Surgery
 (4.6 away) Contact site
  • 04 Apr, 2021
  • +9 other locations
Radiofrequency (RF) Ablation Prospective Outcomes Study

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain.

Carolinas Research Institute
 (5.0 away) Contact site
  • 16 Jul, 2021
  • +7 other locations
Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS ) Real World Outcomes

The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of Differential Target Multiplexed (DTM) programming in the Spinal Cord Stimulation (SCS) implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celri Health and …

spinal cord
limb pain
chronic pain
Carolinas Research Institute - Huntersville
 (4.6 away) Contact site
  • 15 Sep, 2021
  • +25 other locations
Radicava (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

REFINE-ALS is a prospective, observational, longitudinal, multicenter study designed to identify biomarkers to serve as quantifiable biological non-clinical measures of Edaravone effects in ALS. Epigenetic and protein biomarkers will also be investigated.

Atrium Health, Carolinas HealthCare System Neurosciences Institute
 (5.0 away) Contact site
  • 25 May, 2021
  • +42 other locations
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.

Southern Oncology Specialists
 (4.6 away) Contact site
  • 25 Mar, 2021
  • +6 other locations